Professional and proven scientific advice from the initial development of a drug to the submission of a marketing-authorization application and the post-authorization phase.
Guidelines and guidance documents provide good initial overview on drug and device development. Due to their generic nature, however, they rarely apply to real life product development plans. IASON consulting is happy to step in and assists you with proven advice where official documentation has left gaps.
Scientific advice is prospective in nature, focusing on development strategies rather than pre-evaluation of data to support a marketing-authorization application. It helps to integrate cost-effectiveness considerations into your evidence generation plans.
Receive detailed feedback on your clinical development and scientific strategies as well as advice on which studies are necessary.
Receive tailormade advice on the pros and cons of available options with special attention to current standards, regulations, and guidelines.